Mucofortin (Acetylcysteine)

Acetylcysteine works by breaking disulfide bonds in mucus glycoproteins, which reduces the viscosity of the mucus. This action facilitates mucociliary clearance and expectoration. Additionally, it serves as a precursor for glutathione, supporting antioxidant defenses in the respiratory tract.

The appropriate dose of Mucofortin is determined by the prescribing healthcare professional based on the patient’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for acetylcysteine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mucofortin.

To order Mucofortin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mucofortin’s active ingredient, acetylcysteine, directly cleaves disulfide bonds in mucus, offering a rapid reduction in viscosity. Compared with other mucolytics such as carbocysteine or bromhexine, acetylcysteine also provides antioxidant benefits by supporting glutathione synthesis, which may be advantageous in oxidative stress‑related respiratory conditions.

Mucofortin should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not use the product if the packaging is damaged or the product appears discoloured.

Mucofortin is administered orally, typically as a tablet or liquid preparation. The exact form and dosage are prescribed by a healthcare professional. Patients should swallow tablets whole with water or measure the liquid dose accurately using a calibrated device, following the prescriber’s directions.

Serious risks, though rare, include anaphylactic reactions, severe skin reactions such as Stevens‑Johnson syndrome, bronchospasm, marked hypotension, and hepatic dysfunction. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, rash, swelling, or sudden drop in blood pressure.

Mucofortin should be avoided in individuals with known hypersensitivity to acetylcysteine or any excipients in the formulation. Patients with uncontrolled asthma, severe renal impairment, or those taking nitroglycerin without medical supervision should consult a healthcare professional before use.